Elise Klein

Elise Klein

Work History

Work History

Prior Experience

Berlex Laboratories Inc, Subsidiary of Schering AG

Product management roles for flagship brands culminating in Executive Director of Marketing, Berlex Laboratories, Inc., 1983-1993. Launched $200M anti-arrhythmic product, Betapace and gained 6% in market share with OC line of products. Re-launched MRI agent Magnevist generating $100M per year in sales

Drug Regulatory Affairs, responsibilities included advertising and promotion, NDA/ANDA strategy and development, clinical development and manufacturing. 

Oct 2008 - Present

Founder- Chief Strategist

Kleerpointe Management LLC

Developed an independent consulting firm, Kleerpointe Management LLC, providing strategic and operational consulting to emergent biotech and private equity,

Feb 2006 - Jun 2008

VP Global Strategic Marketing Specialized Therapeutics

Led global marketing strategy for existing and pipeline products for $1.7B unit amid climate of organizational transformation, and acquisition by Bayer. Took an underdeveloped unit, developed staff and processes to execute newly defined global responsibilities in a new matrix structure. Core member of Leadership Team, providing strategic and commercial perspective on all portfolio and development decisions.Managed external global partnerships and played key role in guiding portfolio expansion. Managed staff of 13, $50+M budget, and global marketing and sales expenditures of over $400M.

  • Addressed the lagging performance of key brand, Betaseron, through re-positioning, product improvement and increased market and selling effectiveness. Resulted in increased growth from 8% to 15% as of September, 2008.
  • Instituted a global brand team system and built teams for 3 pre-marketed products in Phase 3, resulting in the execution of pre-marketing programs, key opinion leader development and a sustainable publication stream. Initiated global pricing studies and developed global access strategies.
  • Overhauled global sales forecasting process by creating a new model and fostering global adoption. Achieved global alignment and transparency where previously there was resistance, obfuscation and inability to challenge assumptions. Resulted in more aggressive target setting and commitment to goal achievement.
  • Led marketing collaboration between Bayer and Regeneron Pharmaceuticals. Drove agreement on clinical trials by defining a competitive target product profile. Created a development program that supported product differentiation and profitable pricing. Initiated Phase 2 development of a new indication and moved product into Phase 3.
  • Led multiple business unit integration activities post-acquisition by Bayer HealthCare.
    • Undertook commercial evaluation of all projects in portfolio, including 20 year forecasts.
    • Developed 10- year strategic plan with alternate scenarios.
    • Produced the organizational structure and process blueprint adopted by all units, resulting in rapid integration and no loss to productivity.
  • Initiated new life cycle management programs with external partners and in-licensed an inflammation platform.
  • Commercial lead on 2 complex contract re-negotiations with external partners.
2004 - 2006

VP Business Analytics

Berlex Laboratories Inc, Subsidiary of Schering AG

Identified a corporate weakness and subsequently established a new organizational unit to provide decision transforming data and information to operational Sales and Marketing teams. Oversaw IT and sales activities including the development of sales force and marketing efficiencies and competency improvements.

  • Devised the organizational concept, designed structures and processes, and recruited and trained 12 professionals servicing 5 business units and the sales organization.
  • Commissioned and executed a corporate wide IT/data infrastructure audit, and built an enterprise data warehouse a 1st for Schering. Enabled a 25% reduction in annual data costs while improving analytical output.
  • Improved selling efficiency and re-directed selling resources through introduction of revised targeting bybehavioral segmentation. Improved efficiency of oral contraceptive sampling activity, and supported national roll-out of Yasmin DTC campaign.
  • Introduced and implemented a new corporate wide brand planning structure and process, with a focus on effective positioning, competitive analysis and accountability to revenue and profit goals. 
1999 - 2004

VP General Manager Dermatology

Berlex Laboratories Inc, Subsidiary of Schering AG

Created the U.S. Dermatology Division from scratch. Developed and executed a business plan that resulted in a profitable business venture.Led business development, marketing, clinical, medical affairs and sales efforts.

  • Acquired and developed products, and built the required infrastructure for a unit that today is a stand-alone business with a staff of 70 generating $43M+ annually.
  • Identified a unique product opportunity with a declining, older product by leveraging a product feature into a new indication, rosacea. Directed the clinical development of Finacea resulting in a successful NDA filing 18 months from IND filing. Achieved 20% market share in launch year.
  • Negotiated and executed a co-promotion agreement with Allergan and created a development pipeline via acquisition. Conducted due diligence on 15 potential acquisitions, bringing 3 to consummation.
2002 - 2004

Chair of Operating Committee

Berlex Laboratories Inc, Subsidiary Schering AG

Inaugurated the Operating Field Committee, a sub-committee of the Executive Committee, charged with development and delivery of the 3 year operating plan including resource deployment across all Business Units (Women’s Health, Specialized Medicine, Oncology, Diagnostic Imaging, Dermatology). Provided oversight on day-to-day US commercial activities and established policy and procedures. Evaluated and approved all pricing decisions.

1997 - 1999

VP Sales and Business Development

Berlex Laboratories Inc, Subsidiary of Schering AG

Led $650M revenue unit with 6% annual sales growth, including 500-member field sales organization, sales operations, key account, distribution, and contracting groups. Directed a group of 5 scientific and licensing experts dedicated to the identification and development of acquisition opportunities.

  • Transformed the sales organization from being accountable for delivering physician calls to being accountable for generating business growth. Instituted regional and district level sales plans and budgeting.
  • Evolved regional management into local business experts capable of driving business results. Executed a new key account structure focused on customer segments rather than geography.
  • Improved operational line management through staff changes, identification of new talent and establishment of the 1st development program for management candidates.
1993 - 1997

VP General Manager Diagnostic Imaging

Berlex Laboratories Inc

Led $150M U.S. Imaging business, including staff of 50, across marketing, clinical development and medical affairs.

  • Stabilized key brand, Magnevist®, upon entry of 2 competitors following loss of exclusivity in a price sensitive, contracting environment. Maintained 50%+ market share while maintaining high profit levels through development and execution of the 1st account-based decision framework for sales and marketing.
  • Conceived, negotiated and executed an innovative marketing and distribution agreement with Abbott Laboratories.
  • Launched non-ionic iodinated contrast media line. Acquired and launched a novel liver specific MRI imaging agent





Rutgers University



High Impact Leadership/Staff Development

High energy leader with passion for results and a "hands-on" involved style. Works by engaging and inspiring others toward clear and well articulated goals. Proven ability to develop strong performing teams, including cross-functional and global teams. High degree of integrity, ethics and accountability. Track record of identification and development of the next generation of leaders.

Analytical Approach to Decision Making

Skilled in all elements of marketing research, database analysis and forecasting. Led the development of a Data Warehouse and Customer Master to allow for high quality analysis of Sales Force resource analysis and Return on Investment (ROI) analyses. Able to extract insight from internal and external data sources as well as through direct interaction with customers and key opinion leaders.

Organizational Re-Structuring/ Change Management

Leader in design and execution of new structures and processes, including implementation of new global Business Unit structure, development of Business Analytics function, design of global reporting metrics system and redesign and implementation of Brand Planning process. Also re-organized Field and Institutional Sales organizations for customer alignment geographically as well as by major customer group.

Marketing Strategy

US as well as global experience in product positioning, branding, market strategy development and execution. Expert in finding opportunity in competitive market situations. Experienced in product launches as well as product turn-around and life-cycle extension. Experienced in developing patient centric programs to facilitate education and awareness.

Alliance Management

Developed and managed several alliances including licensing, co-development, co-marketing and co-promotion and distribution agreements.

Portfolio Development/Strategic Planning

Proficient in developing strategic plans and developing portfolio for broad therapeutic areas, including MS, immunology, inflammation,Oncology, in-vivo diagnostic imaging and women's health. Commercial lead on majority of acquisition evaluations.


Creating the leaders of tomorrow. Currently an active Mentor for the HealthCare Business Women's Association and a Literacy Volunteer for Project Literacy of Bergen County.


Versatile executive with a formidable record of commercializing assets in competitive market segments by developing novel market strategies and delivering flawless execution in a cost efficient manner. Extensive experience in building successful commercial entities through, alliances, acquisitions and portfolio development (US and Global). Passionate about meeting challenges and creatively overcoming obstacles to build sustainable competitive advantage. Collaborative leader able to engage cross-functional work teams, and build culture of teamwork, accountability and performance